Genesis Molecular AI: Funding, Investors & Team (Sep 2026)
Genesis Therapeutics is a company that has its roots in academic research, which serves as the foundational element of its growing portfolio of AI technologies. The company employs a combination of innovative deep neural networks, biophysical simulation techniques, and highly scalable computing infrastructure. This amalgamation of technologies is geared towards achieving remarkable results in molecular generation and property prediction, particularly in the field of drug discovery and molecular design. Established in 2019 and headquartered in South San Francisco, California, Genesis Therapeutics focuses on leveraging innovative AI methodologies to enhance the efficiency and accuracy of molecular research. The company's approach holds promise in revolutionizing how molecules are generated and analyzed, potentially leading to advancements in drug development and related fields.
Genesis Molecular AI has raised $40.0M across 1 funding round on record, the most recent an undisclosed round of $40.0M announced in May 2026.
That round is above the $5.7M median round size for Artificial Intelligence companies tracked on FundedIQ over the last two years.
Genesis Molecular AI Company Profile and Key Stats
Latest funding round on record: May 2026.
Genesis Molecular AI Funding Rounds
Genesis Molecular AI Founders and Leadership Team
Contact details for the Genesis Molecular AI team: 1 has a LinkedIn profile.
Start 14-day free trial →Genesis Molecular AI Funding Compared to Other Artificial Intelligence Startups
Genesis Molecular AI's latest round of $40.0M is above the median round in Artificial Intelligence. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Genesis Molecular AI in Artificial Intelligence and South San Francisco
Companies Similar to Genesis Molecular AI
Cradlewise is an intelligent baby crib that learns from the baby's sleep patterns, spots the first signs of…
Capacity is an AI-powered helpdesk that automates support for customers and employees. Capacity connects…
AfterQuery is an artificial intelligence research and data platform focused on creating high-quality,…
The future of translation is conversational and Language I/O’s proprietary machine translation optimization…
Greptile is a platform driven by artificial intelligence that evaluates codebases and improves development…
Rhealth is a biotechnology company offering hospitals health management solutions utilizing advanced AI…
Socure is a predictive analytics platform for digital identity verification of consumers. Socure's predictive…
Instinct is an artificial intelligence startup developing AI technology.
Significant gives vehicle-mounted PC vision innovation that distinguishes visual deformities in network…
Cloverleaf AI exists to help you fill your pipeline with high-quality SLED leads. Tell us what you deliver,…
Emerald AI develops software and platforms that manage and coordinate energy use for artificial intelligence…
Genesis Molecular AI Funding FAQs
What does Genesis Molecular AI do?
Genesis Therapeutics is a company that has its roots in academic research, which serves as the foundational element of its growing portfolio of AI technologies. The company employs a combination of innovative deep neural networks, biophysical simulation techniques, and highly scalable computing infrastructure. This amalgamation of technologies is geared towards achieving remarkable results in molecular generation and property prediction, particularly in the field of drug discovery and molecular design. Established in 2019 and headquartered in South San Francisco, California, Genesis Therapeutics focuses on leveraging innovative AI methodologies to enhance the efficiency and accuracy of molecular research. The company's approach holds promise in revolutionizing how molecules are generated and analyzed, potentially leading to advancements in drug development and related fields.
How much funding has Genesis Molecular AI raised?
Genesis Molecular AI has raised $40.0M across 1 round on record. The most recent is an undisclosed round of $40.0M announced in May 2026.
When did Genesis Molecular AI last raise funding?
Genesis Molecular AI's most recent funding round on record is an undisclosed round of $40.0M, announced in May 2026.
Who founded Genesis Molecular AI?
FundedIQ lists Evan Feinberg (Founder) at Genesis Molecular AI.
Where is Genesis Molecular AI headquartered?
Genesis Molecular AI is based in South San Francisco, California, United States.
How many employees does Genesis Molecular AI have?
Genesis Molecular AI is in the 101-250 employee band.
How does Genesis Molecular AI's funding compare to other Artificial Intelligence startups?
Genesis Molecular AI's latest round of $40.0M is above the $5.7M median round size for Artificial Intelligence companies on FundedIQ across 7,234 tracked companies over the last two years.
About FundedIQ's Genesis Molecular AI Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Genesis Molecular AI is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.